Clinical trials in cardiac xenotransplantation: Are we ready to overcome barriers?
Carregando...
Fontes externas
Fontes externas
Data
Orientador
Coorientador
Pós-graduação
Curso de graduação
Título da Revista
ISSN da Revista
Título de Volume
Editor
Hindawi
Tipo
Resenha
Direito de acesso
Acesso restrito
Fontes externas
Fontes externas
Resumo
Heart allotransplantation has become one of the methods of choice in the treatment of severe heart failure. In the face of its difficulties, such as the unmet balance between organ supply and demand, the use of xenotransplantation (XTx) might be an attractive option shortly, even more with the ongoing progress achieved regarding the avoidance of hyperacute rejection and primary organ disfunction, maintenance of xenograft function and control of xenograft growth. To make possible this translational challenge, some points must be taken into account indeed, and they are the equipoise of human benefit and animal suffering, the risk of unknown infections, a well prepared informed consent, ethical and religious beliefs, and the role of cardiac XTx in a ventricular assistance device era.
Descrição
Palavras-chave
Idioma
Inglês
Citação
Journal of Cardiac Surgery, v. 36, n. 10, p. 3796-3801, 2021.
